The Hidden Danger in Skin Creams Sold Without a Prescription in India

Walk into almost any medical store in India and ask for something to clear a rash, lighten a dark patch, or treat a persistent fungal infection. Chances are you will walk out with a cream that contains a corticosteroid, an antifungal, an antibiotic, and sometimes a skin-lightening agent, all in one tube. These fixed-dose combination creams are not a niche product. They are among the most widely dispensed topical preparations in the country, and the gap between how freely they are available and how carefully they should be used is at the centre of a dermatological problem that has been building for decades.

The most common formulations combine a mid- to high-potency corticosteroid such as clobetasol propionate or betamethasone with an antifungal like clotrimazole or miconazole, an antibiotic such as neomycin or gentamicin, and often a melanin-inhibiting agent like hydroquinone. Each of these has a legitimate clinical use in specific, diagnosed conditions. The problem is the combination. A corticosteroid suppresses the local immune response and reduces inflammation. That makes it effective for inflammatory conditions like eczema or psoriasis, but it also suppresses the immune signals that the skin uses to fight fungal and bacterial infections. Applying a steroid to an undiagnosed fungal infection does not treat it. It removes the visible symptoms while allowing the infection to spread under the surface, a presentation dermatologists refer to as tinea incognita.

Corticosteroids work by binding to receptors inside skin cells and altering gene expression. Used for short periods under clinical supervision, this is a controlled, targeted effect. Used for months or years without supervision, the consequences accumulate in predictable ways. The epidermis thins because corticosteroids suppress the production of structural proteins that maintain skin thickness. Blood vessels near the surface dilate and become permanently visible. Collagen in the dermis breaks down, producing stretch marks that are not reversible. The skin's barrier function, which depends on an intact lipid layer and a healthy microbiome, deteriorates. In darker skin tones, which make up the majority of the Indian population, prolonged use frequently causes perioral dermatitis, steroid-induced rosacea, and paradoxical hyperpigmentation, the opposite of the lightening effect many users were seeking. The hydroquinone often included in these formulations carries its own risk profile: used without medical oversight, it can cause ochronosis, an irreversible bluish-black discolouration of the skin that is extremely difficult to treat.

Stopping a potent topical corticosteroid after prolonged use is not straightforward. The skin has adapted to the suppression of its inflammatory pathways. When the steroid is removed, those pathways rebound. The result is a flare that often looks worse than the original condition: intense redness, burning, and sensitivity that can persist for weeks to months. This rebound effect is one of the reasons people continue using these creams long past the point where they should have stopped. The skin flares, the cream brings it back under control, and the cycle reinforces itself. Stopping correctly requires a structured taper under dermatological supervision, not an abrupt discontinuation.

Several factors converge. Prescription-only status for many of these formulations exists on paper but is inconsistently enforced at the point of sale. A significant proportion of people seek advice from pharmacists rather than dermatologists for skin concerns, and pharmacists are not trained to diagnose the conditions these creams are intended for. The marketing of skin-lightening products has created strong consumer demand for anything that appears to brighten skin quickly, and these combination creams often produce a short-term brightening effect through steroid-induced skin thinning that is mistaken for a genuine cosmetic result. Cost and accessibility also matter: a tube of combination cream is cheap and immediately available; a dermatology consultation is neither cheap nor always nearby.

Any persistent skin change, a rash that does not resolve in a week, a patch that is spreading, a pigmentation change, a recurring itch, warrants a clinical diagnosis before treatment begins. A dermatologist can distinguish between conditions that look similar but require entirely different treatment: eczema, tinea, contact dermatitis, and perioral dermatitis can all present as red, inflamed patches, and treating one with the protocol for another will make it worse. If a corticosteroid is genuinely indicated, a dermatologist will choose the appropriate potency for the body site involved, specify the duration, and plan the taper. The face and groin require lower-potency steroids than the palms or soles, because skin thickness and absorption rates differ significantly by site.

Self-selecting a high-potency combination cream and applying it to the face for months is not a version of this. The distinction between a correctly supervised steroid prescription and an over-the-counter combination cream used indefinitely is not a matter of degree. It is a different category of thing entirely. The skin damage these creams cause at scale is real, it is largely preventable, and it begins with a diagnosis that a pharmacist is not equipped to provide.

Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!